🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying the effects of obatoclax mesylate in cell samples from ...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01150656
Obatoclax Mesylate (GMX1777) is a water-soluble, intravenously-administered...
Status
Terminated
Location
University of Pennsylvania
Start Date
2008-06
Trial ID
NCT00724841
Treatments Being Tested
Obatoclax may stop the growth of chronic lymphocytic leukemia by blocking b...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2008-01
Trial ID
NCT00612612
Treatments Being Tested
Defects in the apoptotic process can lead to the onset of cancer by allowin...
Status
Completed
Location
Stanford University
Start Date
2006-12
Trial ID
NCT00413114
Treatments Being Tested
The Phase I portion of this protocol will determine the best phase II dose ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2008-05
Trial ID
NCT00682981
Treatments Being Tested
Defects in the apoptotic process can lead to the onset of cancer by allowin...
Status
Completed
Location
Mayo Clinic College of Medicine
Start Date
2006-10
Trial ID
NCT00405951
Treatments Being Tested
Defects in the apoptotic process can lead to the onset of cancer by allowin...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2006-07
Trial ID
NCT00359892
Treatments Being Tested
This is a randomized, multi-center, open-label study of approximately 24 mo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01563601
Treatments Being Tested
This protocol is being run to determine the best phase II dose and schedule...
Status
Completed
Location
University of CA- San Diego
Start Date
2004-09
Trial ID
NCT00600964
Treatments Being Tested
This phase I trial is studying the side effects and best dose of obatoclax ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2009-06
Trial ID
NCT00933985